Osteoporose
NeuDie Studie ist in Englisch. Um Teil zu nehmen, müssen Sie der englischen oder holländischen Sprache mächtig sein.
- Rauchen
- Rauchen
- Geschlecht
- Mann
- Alter
- 25-55 jaar
Clinical trial of an investigational compound that is being developed for the treatment of immune system diseases.
Note:
As a female you can only participate if you are not pregnant, not breast feeding and meet one of the following conditions:
As a male you can only participate if you meet one of the following conditions;
Part A: The trial consists of 1 period during which you will stay in the research facility in Groningen (location van Swietenlaan 6) for 4 days (3 nights), followed by 8 short visits. The follow-up visit will take place during your last short visit.
Part B: The trial consists of 4 periods during which each period you will stay in the research facility in Groningen (location van Swietenlaan 6 for 4 days (3 nights). The first 3 periods are followed by one short visit. The last period is followed by 6 short visits. The follow-up visit will take place during your last short visit.
Note: You must be available for all dates to be able to participate in this clinical trial. The current dates of the clinical trial will be published on our website.
Travel expenses will be reimbursed based on the distance traveled (€ 0.21 net per kilometer) with a minimum of € 13 and a maximum of € 176.40 (840 kilometers) per round trip, regardless of the mode of transportation.
In this trial it will be investigated how safe the investigational compound is and how well it is tolerated when it is used by healthy participants. Also, it will be investigated how quickly and to what extent the investigational compound is absorbed, transported and eliminated from the body. The investigational compound may potentially be used for the treatment of immune system diseases such as: rheumatoid arthritis (inflammation of joints), gout and inflammatory bowel disease.
The trial consists of two parts: part A and part B. In part A you will receive the study compound once. In part B you will receive the study compound 4 times, once during each period of stay.
Für Deutschland: Bitte beachten Sie: Die Arzneimittelstudien finden im niederländischen Groningen statt. Sie müssen Englisch oder Niederländisch sprechen, verstehen und lesen können, um an einer Studie teilnehmen zu können.